Latest Cure Alzheimer's Fund Stories
Cure Alzheimer’s Fund and National Institute of Mental Health join in awarding millions for Whole Genome Sequencing. Boston (PRWEB) May 09, 2013 The goal of the research project led by Dr. Rudolph Tanzi at Massachusetts General Hospital and funded through collaboration between Cure Alzheimer’s Fund (CAF) and the National Institute of Mental Health (NIMH) is to complete the identification of genes affecting risk for Alzheimer’s disease. The Whole Genome Sequencing (WGS) process will...
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease. The findings, published July 31, 2012 in Molecular Psychiatry, demonstrate renewed potential for this compound and could lead to clinical trials in patients...
Gustavo C. Román M.D., Professor of Neurology, Weill Cornell Medical College and Director of The Nantz National Alzheimer Center a scholarly partnership between The Methodist Hospital Research Institute, Weill Cornell Medical College, and the Weill Cornell Graduate School of Medical Sciences of Cornell University., to join board of LightBridge Healthcare Research, Inc. San Antonio, Texas (PRWEB) July 30, 2012 The Alzheimer’s Caregiver™ today announced that Gustavo C. Román...
PHILADELPHIA, July 10, 2012 /PRNewswire/ -- TREVENTIS Corporation announced today that the Company's scientific founder, Donald F. Weaver, MD, PhD, was named as the Sobey Chair in Alzheimer's disease research at Dalhousie University in Halifax, Nova Scotia, Canada. This is the third endowed chair to be held by Dr. Weaver at Dalhousie. This chair has been established as the result of a $2 million donation to the Dalhousie Medical Research Foundation (DMRF) from the Sobey Foundation....
NEW YORK and WILMINGTON, Mass., April 10, 2012 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and Charles River Laboratories International, Inc. (NYSE: CRL) announced today the recipients of their 2011 partnership award program, Use of Aged Rats as a Relevant Preclinical Model for the Development of Therapeutics for Cognitive Aging and Alzheimer's Disease. The ADDF and Charles River established the award program to accelerate the discovery of new...
NEW YORK, March 13, 2012 /PRNewswire/ -- The Alzheimer's Association, New York City Chapter will host a free community event, open to the public, featuring a panel of experts who will explore the role of genetics in Alzheimer's disease. Titled, "The Role of Genetics in Alzheimer's Disease: An Evolving Landscape," the event will take place on Wednesday, March 14, 2012 at 6:00 p.m. at The Times Center in midtown Manhattan and will be moderated by WCBS-TV Medical Reporter Dr. Max Gomez,...
Dr. Charles "Chuck" A. Wilson to lead science effort looking at effects of the Deepwater Horizon oil spill RESTON, Va., Feb. 24, 2012 /PRNewswire-USNewswire/ -- The Gulf of Mexico Research Initiative (GoMRI) Research Board announced today the selection of Dr. Charles "Chuck" A. Wilson to serve as the GoMRI Chief Science Officer. "I am pleased that Dr. Wilson has accepted this important position," said Dr. Rita Colwell, chairman of the GoMRI Research Board. "His professional...
Directs Research for Study of Rare Childhood Disease DARIEN, Conn., Jan. 25, 2012 /PRNewswire-USNewswire/ -- The RE Children's Project, a non-profit dedicated to supporting scientific research directed towards the treatment and cure of the rare childhood disease Rasmussen Encephalitis, is pleased to announce the formation of a Scientific Advisory Board to oversee research initiatives funded by the non-profit. Appointed to the RE Children's Project Scientific Advisory Board...
The Administration looks to NACDD members to help chart a new course for Alzheimer's treatment. Atlanta, GA (PRWEB) January 21, 2012 NACDD's members David Hoffman and Anita Albright entered the national spotlight this week for their contribution to the government’s advisory committee on Alzheimer’s Disease. Cited in the Seattle Times, Huffington Post, Salt Lake Tribune and CBS News, Mr. Hoffman and Ms. Albright have poured their time, energy and expertise into solving what has...
Historic National Plan Within Reach WASHINGTON, Jan. 18, 2012 /PRNewswire-USNewswire/ -- During the second meeting of the Advisory Council on Alzheimer's Research, Care and Services, in-depth discussions took place about goals and strategies to change the trajectory of Alzheimer's disease. The Department of Health and Human Services also outlined its timetable for the development of a national Alzheimer's plan with the first draft targeted for mid-February and a final plan unveiled...
